Immuron (IMRN) Common Equity (2015 - 2026)
Immuron (IMRN) posted Common Equity of $11.0 million for Q3 2026, up 36.4% on a QoQ basis from $8.1 million in Q4 2025, and up 13603.38% year-over-year from N/an in Q3 2025.
Analysis
Immuron (IMRN) Common Equity (2015 - 2026) Analysis & Trends
Immuron has reported Common Equity for 12 years, with the latest figure at $11.0 million in Q3 2026.
- On a quarterly basis, Common Equity rose 13603.38% year-over-year to $11.0 million in Q3 2026; TTM through Aug 2026 was $11.0 million, a 13603.38% increase from a year earlier, with the FY2026 full-year figure at $11.0 million, up 13603.38% from the prior year.
- Common Equity was $11.0 million for Q3 2026 at Immuron, up from $8.1 million in the prior quarter.
- The five-year high for Common Equity was $16.6 million in Q2 2022, with the low at $80318.3 in Q3 2025.
- Average Common Equity over 5 years is $9.1 million, with a median of $9.7 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Common Equity plunged 98.78% in 2023, then soared 13603.38% in 2026.
- Over 5 years, Common Equity stood at $15.2 million in 2022, then declined by 16.14% to $12.8 million in 2023, then sank by 34.92% to $8.3 million in 2024, then slipped by 2.92% to $8.1 million in 2025, then jumped by 36.4% to $11.0 million in 2026.
- The last three Common Equity figures came in at $11.0 million (Q3 2026), $8.1 million (Q4 2025), and $80318.3 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 11.69 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 11.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 20.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 31.71 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 8.42 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 6.76 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 18.85 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 4.92 Bn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | 11.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 11.01 Mn |
| Dec 31, 2025 | 8.07 Mn |
| Sep 2, 2025 | 80,318.33 |
| Jun 30, 2025 | 5.17 Mn |
| Dec 31, 2024 | 8.31 Mn |
| Sep 9, 2024 | 84,687.47 |
| Jun 30, 2024 | 8.38 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 28, 2023 | 12.86 Mn |
| Aug 30, 2023 | 196,168.36 |
| Jun 30, 2023 | 13.11 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Aug 31, 2022 | 16.12 Mn |
| Jun 30, 2022 | 16.60 Mn |
| Dec 31, 2021 | 18.96 Mn |
| Sep 30, 2021 | 19.04 Mn |
| Jun 30, 2021 | 19.94 Mn |
| Dec 31, 2020 | 4.13 Mn |
| Sep 1, 2020 | 62.43 Mn |
| Jun 30, 2020 | 3.70 Mn |